Skip to Content

Sarecycline use while Breastfeeding

Drugs containing Sarecycline: Seysara

Medically reviewed by Drugs.com. Last updated on Feb 2, 2021.

Sarecycline Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of sarecycline during breastfeeding. For acne treatment, it is taken for 12 weeks or longer. Such prolonged courses of tetracyclines are not recommended because if even a small fraction is absorbed by the infant from milk, it could have a cumulative staining effect on the infant’s permanent teeth.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Sarecycline

CAS Registry Number

1035654-66-0

Drug Class

Breast Feeding

Lactation

Anti-Infective Agents

Antibacterial Agents

Tetracyclines

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.